Phase 3 Osteoarthritis Trial, Recruiting NCT06704893 Sponsor: Chang Gung Memorial Hospital Condition: Osteoarthritis
Back to Osteoarthritis

Phase 3 Osteoarthritis Trial, Recruiting

NCT06704893
Recruiting Phase 3

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged between 18 and 80 years old
  • People with a body mass index (BMI) below 40 (a measure of body weight relative to height)
  • People who have knee osteoarthritis with symptoms and X-ray results showing a moderate level of joint damage (rated as grade 2 or 3 on a standard medical scale)
  • People who have rated their knee pain higher than 4 out of 10 on average over the past 7 days
  • People who are able to walk on their own or with the help of a walking cane

Who may not be able to join:

  • People who are pregnant or planning to become pregnant
  • People who regularly take blood-thinning medications (anticoagulants)
  • People who have used pain relief medications (other than paracetamol/acetaminophen) within the 15 days before receiving the injection
  • People with a history of substance abuse
  • People who take any additional medications for knee symptoms during the study without reporting this to the research team
  • People who have had a cortisone injection or joint fluid supplement injection into the affected knee within the past 3 months
  • People who have had surgery on the affected knee within the past 12 months, or surgery on the opposite knee within the past 6 months
  • People with a history of organ transplant or bone marrow/stem cell transplant
  • People currently taking medications that suppress the immune system
  • People who have been diagnosed with cancer in the past 5 years (except for a type of skin cancer called basal cell carcinoma that has already been treated)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 23 July 2026
Phase 3: approximately ~65% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.
Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
21 October 2024
Est. completion
31 December 2027

Where this trial is recruiting

🇹🇼 Taiwan

Primary endpoints

Visual Analog Scale (VAS); Knee Injury and Osteoarthritis Outcome Score (KOOS); The World Health Organization Quality of Life Brief Version (WHOQOL-BREF)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov